Erin Schaefer, Former Google/YouTube Senior Executive, Joins Roundtable Board to Help Guide Premium-Media OS Growth

Roundtable (RTB) announced a 10-year, $1 billion deal with Paradium.AI (PAAI) to migrate PAAI's media portfolio onto RTB's AI/DeFi MediaOS. RTB expects $100 million annual revenue and EBITDA positivity, with 100 million monthly consumers. The partnership aims to reduce costs, increase profits, and provide global scale for media brands.

Roundtable (NASDAQ: RTB) said it launched real-time onchain ad-payment infrastructure for professional publishers, enabling nearly 200 publishers to receive USDC as soon as ad revenue is earned. Coinbase will provide wallet support and USDC payment rails via Coinbase Prime. The company says its Media Liquidity Pool and smart-wallet network settle transactions instantly and record them on-chain.

First Tracks Biotherapeutics (TRAX) reported positive results from a Phase Ib study of ANB033 for celiac disease, showing significant symptom reduction and fewer adverse events compared to placebo. The company plans to present results at ICDS in November and expects cohort two data in Q1 2027. ANB033 targets both IL-15 and IL-2, differentiating it from other therapies. The FDA has granted Fast Track designation, and late-stage trials are anticipated in 2027.

Quantum BioPharma (QNTM) signed a study start-up agreement with Thermo Fisher Scientific for its Phase 2 Lucid-MS trial for multiple sclerosis, following FDA clearance. The trial will evaluate efficacy, safety, and tolerability. MS affects 2.8 million people globally, with the therapeutic market projected to exceed $38B by 2030, according to the company.

L3Harris has won a $250 million contract from Lockheed Martin to produce rocket propulsion units. The deal highlights L3Harris's role in aerospace and defense manufacturing.

Stryker invested $400M in CMR Surgical, becoming its exclusive U.S. distributor. CMR's robotic system received FDA clearance last year for gallbladder procedures, with over 45,000 procedures performed globally by early 2026, according to J.P. Morgan.